Phase 1 study of OP-02
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Cholesteryl palmitate/colfosceril palmitate (Primary)
- Indications Otitis media
- Focus Pharmacodynamics
- 09 Aug 2017 According to a Novus Therapeutics media release, the company is planning to start this trial in 2018.
- 10 May 2017 According to Tokai Pharmaceuticals Media Release, Tokai Pharmaceuticals has merged with Otic Pharma and subsequently changed its name to Novus Therapeutics.
- 28 Dec 2016 New trial record